CIP2A and hepatocellular carcinoma: Furthermore, the evidence that CIP2A plays a major role in mediating bortezomib induced apoptosis and autophagy in HCC cells suggests that CIP2A may be a potential new drug target in HCC and that compounds/drugs that act as CIP2A inhibitors may have therapeutic potential in HCC.